- 1Department of Forensic Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan
- 2Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan
Objective: The Japanese Ministry of Health, Labour and Welfare introduced the “severe and chronic” criteria to describe conditions associated with long-term psychiatric hospitalization. This study examined factors contributing to prolonged hospitalization in Medical Treatment and Supervision (MTS) Act wards using these criteria.
Methods: The “severe and chronic” criteria comprise three components: “Psychiatric symptoms,” “Behavioral disorders,” and “Life disorders”. As of January 10, 2014, 210 patients hospitalized in MTS Act wards for 1.5 years were enrolled. Treatment outcomes were assessed at 1.5, 2.5, and 3.5 years, and associations between hospitalization duration and each criterion were analyzed.
Results: By 3.5 years, 185 patients had been discharged. At this timepoint, “Psychiatric symptoms” and “Life disorders” were significantly associated with hospitalization outcomes. Twenty individual items—primarily subitems of “Psychiatric symptoms” and “Life disorders”—were consistently related to hospitalization at all timepoints (p < 0.05).
Conclusions: The “Psychiatric symptoms” and “Life disorders” components of the “severe and chronic” criteria were significantly associated with hospitalization outcomes in MTS Act wards.
1 Introduction
Forensic mental health facilities are being established globally to improve the mental condition of offenders with mental disorders and reduce recidivism risk. In Japan, the judicial mental health system was reformed in 2005 with the enactment of the “Act on Medical Treatment and Observation for Persons Who Have Seriously Injured Others While in a State of Insanity,” commonly referred to as the Medical Treatment and Supervision (MTS) Act (1). Under this system, individuals who commit serious offenses while in a state of insanity or diminished capacity are managed through a designated judicial framework. During these proceedings, the prosecutor files a motion, and the district court issues a treatment decision. The panel comprises one judge and one psychiatrist holding a national license as a mental health examiner.
The panel may issue one of three decisions: admission to an MTS Act ward for inpatient treatment, outpatient treatment in the community, or exclusion from the MTS system. Offenders ordered into the system receive specialized psychiatric care in designated medical institutions and are continuously monitored by rehabilitation coordinators based in probation offices. This framework allows individuals who committed offenses while mentally ill to receive coordinated treatment under the jurisdiction of both the courts and the Ministry of Justice, marking a new era in Japanese forensic mental health services (2).
Since then, Japan’s MTS medical observation system has operated for approximately 17 years and is becoming an established component of psychiatric care. The system is characterized by structured rehabilitation processes and inter-agency collaboration that aim to reintegrate offenders into the community while reducing recidivism (3). It provides active treatment through multi-professional and multi-institutional collaboration, promoting the social rehabilitation of individuals with mental disorders who committed serious offenses while in a state of insanity or diminished capacity (4–6). The MTS Act wards are divided into units for acute, recovery, and social reintegration, and shared care (for women), and patients move between units as their treatment progresses. This clarifies the patients and treatment goals in each unit, and allows for the provision of an environment and treatment content suited to each treatment stage.
The MTS Act treatment guidelines divide hospitalization into three phases: acute (3 months), recovery (9 months), and social reintegration (6 months), with specific goals for each stage. The intended duration of hospitalization is approximately 18 months. This framework was originally established by the MHLW (7). In the acute phase, objectives include improving psychopathological symptoms and mental status, promoting physical recovery and psychological stability, confirming treatment motivation, and establishing a therapeutic alliance. During the recovery phase, goals focus on enhancing illness insight and self-control, restoring daily living skills through participation in structured treatment programs, and achieving clinical stability sufficient for supervised walks and brief outings. In the social reintegration phase, aims include maintaining stability to permit extended outings and overnight stays, fostering acceptance of disability through therapeutic engagement, restoring independent living skills such as medication adherence and financial management, and preparing for community reintegration (8). These objectives were defined by the MHLW (8).
However, as of July 15, 2015, 2,564 individuals hospitalized in MTS Act wards had an average stay of 940 days (median: 758 days), equivalent to approximately two years. Nearly 20% of patients had been hospitalized for three years or more—double the standard hospitalization period—highlighting a critical issue in Japan’s medical observation system (9).
Prolonged hospitalization in forensic psychiatric facilities is a widespread issue globally (10, 11). In the United Kingdom, extended hospital stays often result from delays in reducing security levels and repeated transfers between high- and medium-security hospitals. Although progress is being made in understanding the outcome of personality disorders, and it is now known that self-mutilation and help-seeking suicide threats or attempts resolve relatively quickly (12), factors such as comorbid personality disorders, histories of self-harm or violence, and challenges in treatment responsiveness during psychiatric care also contribute to prolonged hospitalization (13). Identifying factors associated with extended stays and preventing unnecessary prolongation are essential to support successful social reintegration. Internationally, studies have identified several contributing factors to extended hospital stays in forensic settings, such as lack of community placement options, high security needs, and inadequate discharge planning. In England, a mixed-methods study found that long-stay patients often remained institutionalized not due to active clinical risk but because of systemic issues such as limited inter-unit coordination and inconsistent discharge criteria (11, 13). For instance, in the United Kingdom, system-level barriers, such as difficulties in transferring between secure units, have been cited as major contributors to long stays (13). Additionally, comorbid substance use, treatment resistance, and legal complexities are recurrent themes in Europe and North America (10, 11).
Long-term hospitalization for schizophrenia—a condition that accounts for most patients in MTS Act wards—is also a global concern in general psychiatry. Identifying factors contributing to prolonged hospitalization in individuals with schizophrenia is essential to prevent unnecessary institutionalization (14–17). As of March 31, 2013, a provisional standard for defining “severe and chronic” cases in Mental Health and Welfare Law wards was developed by the Comprehensive Research Project for Measures for Persons with Disabilities, funded by research grants from the MHLW (18). This standard focuses on patients with chronic disease progression, high clinical severity, behavioral pathology, or treatment resistance, rather than those who remain hospitalized due to a lack of community support. In other words, the interim criteria target clinical factors underlying long-term hospitalization, excluding so-called “social hospitalization”. As of March 31, 2016, “physical complications” were removed from consideration, and a revised criterion was developed to reflect this change (Figure 1; 19).
Figure 1. Proposed “severe and chronic” criteria for psychiatric patients. “Physical complications” refer to cases that require inpatient treatment. These cases are classified into the “severe and chronic” subgroups.
Given the shared aim of facilitating rehabilitation and preventing chronic institutionalization, these criteria may also be relevant to MTS Act wards. However, their applicability to forensic psychiatric settings has not been empirically examined yet. To identify factors contributing to long-term hospitalization for patients in MTS Act wards, this study examined all patients hospitalized for 1.5 years or more (the standard maximum hospitalization period set by the Ministry of Health, Labour and Welfare) in 32 MTS Act wards in Japan as of January 10, 2014, to determine whether they met the “severe and chronic” criteria 1.5, 2.5, and 3.5 years after enrollment. The large-scale survey was only examined by a research group associated with MHLW and has not yet been published. This study was conducted by a research group associated with MHLW, and the authors were given permission to conduct their analysis.
2 Materials and methods
2.1 Subjects
An initial survey was conducted on January 10, 2014, targeting patients hospitalized for 1.5 years or longer in 32 designated inpatient facilities nationwide, established under the MTS framework designated by the MHLW. Of the 791 patients hospitalized in MTS Act wards on that date, 563 had been hospitalized for less than 1.5 years and were excluded. Among the remaining 228, two declined participation after being informed about the study, resulting in an inclusion rate of 99.1%. After excluding 10 patients with unknown outcomes and six who were transferred to other hospitals, a final total of 210 patients were enrolled.
2.2 Methods
This prospective cohort study examined patients hospitalized under the MTS Act for 1.5 years or longer, using data from 32 designated institutions nationwide. Cox regression and descriptive statistics were used for analysis. In 2015, the MHLW Research Group established criteria for identifying “severe and chronic” psychiatric patients (Figure 1). These criteria include four components: “Psychiatric symptoms,” “Behavioral disorders,” “Life disorders,” and “Physical complications (18)”. To distinguish “Psychiatric symptoms” as a specific criterion for “severe and chronic” status — rather than general psychiatric symptoms — we enclosed the term in quotation marks (18).
2.2.1 Psychiatric symptoms
Psychiatric symptoms were assessed using the Brief Psychiatric Rating Scale (BPRS), a widely-validated instrument for evaluating the severity of psychiatric symptoms. The BPRS consists of 18 items: conceptual disorganization, grandiosity, hostility, suspiciousness, hallucinatory behavior, excitement, emotional withdrawal, blunted affect, somatic concern, anxiety, guilt feelings, tension, mannerisms and posturing, depressive mood, motor retardation, uncooperativeness, unusual thought content, and disorientation.
Patients scoring ≥45 on the Overall version of the BPRS or ≥6 on any individual item from the subscale were classified as having “psychiatric symptoms”. Positive symptom scores were calculated by summing the scores for conceptual disorganization, grandiosity, hostility, suspiciousness, hallucinatory behavior, and excitement. Negative symptom scores comprised emotional withdrawal and blunted affect. The comprehensive psychopathology score included the remaining ten items: somatic concern, anxiety, guilt feelings, tension, mannerisms and posturing, depressive mood, motor retardation, uncooperativeness, unusual thought content, and disorientation. These subscale scores, along with the total BPRS score, were included in the analysis.
2.2.2 Behavioral disorders
Behavioral disorders were assessed using 27 items: suicidal ideation, suicidal behavior, verbal outbursts, physical violence, impulsiveness, property damage, seeking others, sexual acts, arson, incontinence, mysophilia, disrobing, collectomania, epileptic seizures, irritability, poor concentration, fixation on specific objects or individuals, stress intolerance, medication non-compliance, refusal to assist, wandering, hyperactivity or inactivity, compulsions, appetite changes, polydipsia, pica, and substance use. These items, derived from the Problem Behavior Evaluation Chart, represent clinical behaviors commonly observed in long-term psychiatric inpatients. Notably, some items—such as poor concentration—may reflect cognitive impairment rather than discrete behavioral disturbances. Prior research has linked such impairments with treatment resistance and functional decline, which may indirectly contribute to prolonged hospitalization. Patients were classified as having behavioral disorders if they scored ≥1, indicating the behavior occurred “about once or twice a month”. According to the provisional criteria for “severe and chronic” status, two subscores were calculated: an A score, related to self-harm and harm to others (suicidal ideation, suicidal behavior, verbal outbursts, physical violence, impulsiveness, property damage, seeking others, sexual acts, and arson); and a B score, encompassing the remaining items. Both subscores, along with the presence of behaviors occurring at least once or twice a month, were included in the analysis.
2.2.3 Life disorders
Based on the official medical certificate for persons with disabilities in Japan, functional status was assessed using 15 items: mobility in bed, transferring, eating, continence, bathing, dressing and undressing, meal preparation, daily living rhythm, hygiene, financial management, medication use, interpersonal relationships, telephoning, shopping, and transportation. These items were adapted from the Ability Disability Evaluation and align with standard indicators of functioning under Japan’s disability framework. Their relevance to social integration and rehabilitation planning has been supported by prior research, highlighting their utility in evaluating discharge readiness. A score of 4 or higher on the Ability Disability Evaluation was considered indicative of substantial support needs in daily functioning. Based on clinical guidance from the Act on Support and Support for Persons with Disabilities, subscores were calculated as follows: the behavioral disabilities score included mobility in bed, transferring, eating, continence, bathing, and dressing/undressing; the community life disorders score included meal preparation, living rhythm, hygiene, financial management, medication use, and interpersonal relationships, as presented in the 2007 National Welfare Office Directors Conference as core elements of community life; and the social adaptation interference score comprised telephoning, shopping, and transportation. These subscores, along with the threshold of daily life difficulty (score ≥4), were included in the analysis.
2.2.4 Physical complications
Patients were considered to have physical complications if they presented with conditions such as water intoxication, recurrent ileus, or recurrent pneumonia during hospitalization in MTS Act wards. Physical comorbidities are common among individuals with mental disorders. Conversely, in Japan’s aging society, the incidence of mental illness — including depression and dementia — among older adults is notably high. Therefore, addressing the comorbidity of physical and psychiatric conditions is a critical concern. In recognition of this, “Physical complications” were added to the provisional criteria for identifying “severe and chronic” cases. Although such physical complications occur in only about 10% of inpatients and are generally secondary to psychiatric symptoms, they were classified as a distinct subgroup within the “severe and chronic” criteria. Importantly, no patients met the criteria for both “Psychiatric symptoms” and “Physical complications” without also meeting criteria for either “Behavioral disorders” or “Life disorders.” As a result, there was no difference in the total number of patients identified using the provisional versus the proposed “severe and chronic” criteria. Physicians at participating institutions assessed patients using the provisional “severe and chronic” criteria based on medical records. Scores were subsequently revised according to the proposed criteria. The primary survey collected data on age, sex, duration of hospitalization, psychiatric diagnosis, and treatment outcomes. Diagnoses were coded using the International Statistical Classification of Diseases and Related Health Problems, 10th Edition (ICD-10). Patient outcomes — categorized as discharged, still hospitalized, or transferred — were recorded at 1.5, 2.5, and 3.5 years using an outcome questionnaire. These outcomes reflect status as of the respective survey dates, rather than the specific discharge dates. July 15 was selected as the outcome survey date, as it marks the anniversary of the MTS Act’s implementation. The research group defined the 1.5-, 2.5-, and 3.5-year follow-ups as corresponding to more than 3, 4, and 5 years, respectively, since initial hospitalization.
2.3 Statistical analysis
Cox regression analysis was conducted to examine the association between clinical variables and treatment outcomes (discharged vs. inpatient) at 1.5, 2.5, and 3.5 years. The dependent variable was outcome status, while independent variables included age, sex, duration of hospitalization at the time of the survey, and the components of the proposed “severe and chronic” criteria (“Psychiatric symptoms,” “Behavioral disorders,” “Life disorders”) as well as “Physical complications”. Given the previously established association between psychiatric hospitalization duration and both age and sex in MTS Act wards, these variables were included as covariates in the analysis (20).
Additionally, multiple linear regression analysis was performed using the actual length of stay (in days) as the dependent variable. Independent variables included age, sex, psychiatric diagnosis, and the three primary components of the proposed “severe and chronic” criteria. This analysis was conducted to capture a more nuanced understanding of hospitalization duration, independent of policy-defined time points. However, despite repeated attempts at multiple regression analysis, there were missing values for 1.5-year timepoint.
To identify factors contributing to long-term hospitalization, we conducted Cox proportional hazards regression analysis using discharge outcome as the dependent variable. Independent variables included the components of the proposed criteria — “Psychiatric symptoms,” “Behavioral disorders,” and “Life disorders” — as well as “Physical complications,” their sub-items, and hospitalization duration. A hazard ratio significantly less than 1 was interpreted as indicative of a lower likelihood of discharge. For exploratory purposes, no Bonferroni correction was applied. Statistical significance was defined as p < 0.05.
Statistical analyses were conducted using SPSS for Windows, version 20.0 (IBM Corp., Armonk, NY).
2.4 Ethical approval
Ethical approval was obtained from the Ethics Committee of the National Center of Neurology and Psychiatry (Approval No. A2014-004; study title: Investigation of the Criteria for “Severe and Chronic” in Medical Observation Law Wards). The study was conducted in accordance with the latest revision of the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment.
3 Results
3.1 Subject summary
The 210 enrolled subjects had a mean hospitalization duration of 1,026 days (95% confidence interval [CI]: 974–1,079; median: 943 days). By July 15, 2015, 126 patients (60.0%) had been discharged; by July 15, 2016, 166 (79.0%); and by July 15, 2017, 185 (88.1%). As of the final survey, 25 patients (11.9%) remained hospitalized in MTS Act wards (Table 1). The median length of stay was 943 days at baseline, increasing to 1,516 days at 1.5 years, 1,950.5 days at 2.5 years, and 2,246 days at 3.5 years. Median lengths of stay were consistently longer for men than for women. Of the total sample, 171 patients (81.4%) were male, and 186 (88.6%) were diagnosed with ICD-10 F2 disorders (schizophrenia, schizophreniform disorder, or paranoid disorder). Among male patients, 11 (6.4%) were diagnosed with F1 disorders (mental and behavioral disorders due to psychoactive substance use), three (1.8%) with F0 disorders (organic, including symptomatic mental disorders), two (1.2%) with F3 disorders (mood disorders), one (0.6%) with an F4 disorder (neurotic, stress-related, and somatoform disorders), two (1.2%) with F8 disorders (developmental disorders), and one (0.6%) with a G40 condition (epilepsy). Among female patients, four (10.3%) were diagnosed with F3 disorders (Table 2). The mean age of the sample was 44 years (95% CI: 42–46 years). Regarding index offenses, 63 male cases (36.8%) involved injury, while 13 female cases (33.3%) involved attempted murder. The most common offenses were injury (34.8%), attempted murder (19.5%), arson (18.1%), and homicide (17.6%), followed by robbery (3.3%), indecent assault (3.3%), attempted arson (1.9%), and attempted robbery (1.4%). Robbery, indecent assault, and attempted arson were reported only among male patients (Table 3). In terms of physical complications, 15 patients had water intoxication, eight had recurrent ileus, four had recurrent pneumonia, and 15 had other physical complications. A total of 28 patients presented with at least one physical complication.
Seventy-nine subjects met the proposed “severe and chronic” criteria (Table 1). Under the proposed framework, “Physical complications” were treated as a subgroup of the “severe and chronic” classification and therefore were not included in the primary category. Among the 28 subjects with “Physical complications,” 16 also met the criteria for “Psychiatric symptoms”. Notably, no subject met criteria for both “Psychiatric symptoms” and “Physical complications” without also exhibiting “Behavioral disorders” or “Life disorders”. As a result, the total number of subjects classified as “severe and chronic” remained unchanged when transitioning from the provisional standard to the proposed criteria.
3.2 Subject outcomes and involvement of three items included in proposed “severe and chronic” criteria
Table 4 presents the associations between discharge status (discharged vs. hospitalized) at 1.5, 2.5, and 3.5 years and the following variables: age, male sex, “Psychiatric symptoms,” “Behavioral disorders,” “Life disorders,” “Physical complications,” and hospitalization duration.
“Psychiatric symptoms” and “Life disorders” were significantly associated with continued hospitalization at 1.5 and 3.5 years (p < 0.05). At 2.5 years, only “Life disorders” remained significantly associated with ongoing hospitalization. In contrast, “Behavioral disorders,” Age, Sex, “Physical complications,” and length of hospitalization at baseline were not significantly associated with hospitalization status at any timepoint.
3.3 Subject outcomes and involvement of sub-items of proposed “severe and chronic” criteria
Tables 5–8 and Supplementary Tables 1 and 2 present the results of the Cox regression analysis for exploratory purposes, including estimated regression coefficients, hazard ratios, 95% CIs, p-values, and significance levels for discharge and continued hospitalization at 1.5, 2.5, and 3.5 years. Analyses were conducted for the sub-items of “Psychiatric symptoms,” “Behavioral disorders,” “Life disorders,” and “Physical complications”. Notably, among the “Behavioral disorders,” only suicidal ideation had a hazard ratio greater than 1 and was significantly associated with discharge. When comparing outcomes at 3.5 years with those at 1.5 and 2.5 years, the following sub-items were consistently associated with prolonged hospitalization across all timepoints (p < 0.05).
Table 6. Behavioral disorders (about once or twice a month or more in the Behavior Evaluation Chart) 3.5 years after the date of the survey.
Table 7. Life disorders (≥4 in ability/disability evaluation) at 3.5 years after the date of the survey.
Table 8. Physical complications (to the extent that inpatient treatment is required) at 3.5 years after the date of the survey and years and days of hospitalization until the date of the survey.
Psychiatric symptoms: positive symptoms, conceptual disorganization, suspiciousness, hallucinatory behavior, excitement, uncooperativeness, unusual thought content, and total BPRS score.
● Behavioral disorders: impulsiveness, B-item total score, and resistance to stress.
● Life disorders (score ≥ 4): community life disorders, living rhythm, hygiene, financial management, medication adherence, interpersonal relationships, acts interfering with social adaptation, telephoning, shopping, overall daily living ability, and the total daily life disorder score.
Additionally, certain items—such as comprehensive psychopathology (within “Psychiatric symptoms”) and behaviors including habits, posture, and undressing (within B-items of “Behavioral disorders”)—were significantly associated with hospitalization at 1.5 or 2.5 years but not at 3.5 years. No sub-items within the “Physical complications” category were significantly associated with hospitalization status at any timepoint. In addition to the Cox regression analysis, we conducted multiple regression analysis using the total number of hospitalization days as the dependent variable to provide a continuous perspective on hospitalization duration. At 3.5 years, male sex (B = 199.57, p = 0.0408), psychiatric symptoms (B = 202.17, p = 0.0288), and life disorders (B = 255.88, p = 0.0072) were significantly associated with longer hospital stays. At 2.5 years, male sex was also significantly associated with prolonged hospitalization (B = 203.08, p = 0.0076). These findings reinforce the contribution of these variables to long-term inpatient care in forensic psychiatric settings.
4 Discussion
To the best of our knowledge, this is the first study to describe the characteristics of psychiatric patients following long-term hospitalization in MTS Act wards in Japan. We applied the proposed “severe and chronic” criteria — originally developed for Mental Health and Welfare Law wards — to a forensic population, with outcomes tracked over a 3.5-year period. Of the 228 eligible individuals hospitalized for at least 1.5 years as of January 10, 2014, data from 226 (99.1%) were analyzed, reflecting a high inclusion rate.
This study is novel in three key respects: (1) it represents the first application of the proposed “severe and chronic” criteria to a forensic psychiatric population, (2) it identifies individual components most predictive of continued hospitalization, and (3) it offers a longitudinal, nationwide analysis of outcomes in MTS Act wards.
Under the Mental Health and Welfare Law, a “severe and chronic” classification is based on illness severity at a defined reference point and includes the following components: “Psychiatric symptoms,” “Behavioral disorders,” “Life disorders,” and “Physical complications”. Although “Physical complications” were initially hypothesized to contribute to long-term hospitalization, they were excluded from the final criteria due to a lack of significant association.
4.1 Factors for long-term hospitalization
Our analysis indicated that key components of “Psychiatric symptoms” and “Life disorders” were significantly associated with the length of hospitalization, consistent with previous findings (Table 4; 21, 22). In contrast, the major components of “Behavioral disorders” and “Physical complications” — the latter ultimately excluded from the proposed criteria — did not show a strong association with hospitalization duration. However, a limited number of sub-items within “Behavioral disorders” were associated with long-term hospitalization. This approach revealed that male sex, psychiatric symptoms, and life disorders were significantly associated with longer hospitalization at 3.5 years, while male sex was also a significant factor at 2.5 years. These findings underscore the relevance of demographic and clinical predictors in explaining long-term institutionalization and suggest that certain associations, particularly those involving sex, may emerge more clearly when considering cumulative hospital stay rather than timepoint-specific discharge.
Importantly, analysis of “Psychiatric symptoms,” “Behavioral disorders,” “Life disorders,” and “Physical complications” (Table 5; Supplementary Tables 1, 2) revealed that positive symptoms and total scores within “Psychiatric symptoms,” as well as community life disorder and acts interfering with social adaptation under “Life disorders,” were significantly associated with prolonged hospitalization. Previous studies have also identified associations between hospitalization duration and positive symptoms measured by the BPRS (23), anxiety, depressive mood, financial difficulties (within “Life disorders”), as well as age and sex (24, 25). With respect to “Behavioral disorders,” B items—particularly resistance to stress—were associated with longer hospitalization. Although prior research identified aggressive behavior (26) and substance use (27) as contributors to extended stays, these associations were not confirmed in the present analysis. Suicidal ideation, notably, was found to be significantly associated with shorter hospitalization in this study, similar findings have been found in previous studies, such as a Canadian study of patients with schizophrenia (28, 29). For instance, a recent study reported that patients admitted for serious overdose remained hospitalized longer due to heightened medical and psychiatric risk, underscoring contextual and diagnostic variability across samples (30). Regarding “Physical complications,” no significant association was observed in this cohort, likely due to the low prevalence (approximately 10%) of such conditions. This finding differs from earlier studies linking diabetes mellitus (30), electrolyte imbalance and hypotension (31), and cardiovascular and metabolic diseases (32) with longer hospital stays (33). However, water intoxication, ileus, and pneumonia are common physical complications in psychiatric hospitalized patients, and may be factors for poor prognosis. Polydipsia may identify a subset of schizophrenia patients whose enhanced stress reactivity contributes to their mental illness (34). Constipation is a common problem during clozapine treatment which can progress to full-blown ileus which can be fatal (35). Advanced age, underweight, smoking habit, use of atypical antipsychotics, and large doses of antipsychotics were risk factors for pneumonia that is a major cause of death in patients with schizophrenia (36). In the “severe and chronic” criteria, it is thought that there was no significant difference in “Physical complications” because there were few people who met the criteria, but if “Physical complications” are expanded to include milder cases, it is possible that they could become a factor in long-term hospitalization. Additionally, no significant associations with age or sex were observed in this analysis, which diverges from prior findings in general psychiatry settings. For instance, a study found that older age and male sex were independently linked to longer psychiatric stays, suggesting that demographic influences may operate differently in forensic versus civil psychiatric population (37). This may reflect differences in demographic composition between patients in Mental Health and Welfare Law wards and those in MTS Act wards.
4.2 Limitations of the present study
This study has several limitations that should be considered when interpreting the findings. First, the number of participants in MTS Act wards was limited compared to those in Mental Health and Welfare Law wards, which imposed a physical constraint on sample size. Second, the duration of hospitalization prior to the survey varied among participants, and this variability was not incorporated into the analysis. Third, although most participants were diagnosed with schizophrenia, individuals with other psychiatric conditions were also included. Fourth, only the primary psychiatric diagnosis was recorded; comorbidities such as personality disorders and alcohol or drug addiction were not captured.
Fifth, post-discharge factors—including family relationships, residential environment, and community reintegration—were not examined, limiting the scope of interpretation regarding real-world outcomes. Prior studies have highlighted the impact of family involvement, institutional characteristics, and system-level predictors of length of stay and readmission, suggesting that these unmeasured variables may have influenced the results. Sixth, multiple comparisons were not adjusted for, given the exploratory nature of the study and the large number of variables assessed. This decision was intended to facilitate hypothesis generation for future research. Seventh, socioeconomic status and educational attainment — both known to influence psychiatric hospitalization duration — were not included due to constraints imposed by the predefined parameters of the study, which were determined by a research group affiliated with the MHLW. Eighth, the findings may not be generalizable to patients under the Mental Health and Welfare Law due to differences in legal frameworks and ward structures. In addition, various sociodemographic and clinical differences between the analyzed groups also may limit generalization. This study was limitedly carried in forensic psychiatric facilities in Japan, and because healthcare systems and forensic psychiatric care systems vary from country to country, there may be limitations to the generalizability of these results to other countries and healthcare systems. Ninth, data collection and analysis were both conducted by entities under the jurisdiction of the MHLW, raising the potential for institutional bias. Tenth, the follow-up intervals of 1.5, 2.5, and 3.5 years reflect time elapsed since the study’s initiation and do not directly represent individual patient length of stay. Additionally, the multiple regression analysis could not be performed for the 1.5-year timepoint due to insufficient data. As a result, findings from this method primarily reflect outcomes at 2.5 and 3.5 years, and interpretations should be made within that context. However, tracking patients hospitalized for more than 1.5 years over an additional 3.5-year period enabled identification of individuals at risk for long-term hospitalization. Finally, this study did not assess facility-level variation in resources or clinical practices, which may significantly affect hospitalization duration; future research should employ multilevel models to account for such institutional factors.
In conclusion, by applying the proposed “severe and chronic” criteria to a forensic psychiatric population, this study identified significant associations between prolonged hospitalization and major components of “Psychiatric symptoms,” “Life disorders,” and selected sub-items of “Behavioral disorders”. These findings offer important implications for discharge planning, clinical prioritization, and policy development within forensic mental health services.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by The Ethics Committee of the National Center of Neurology and Psychiatry (Ethics Committee Approval No. A2014-004, Subject: Investigation of the criteria for “severe and chronic” in the medical observation law wards). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
NT: Writing – original draft, Data curation, Formal Analysis. HK: Methodology, Supervision, Writing – review & editing. NW: Methodology, Supervision, Writing – review & editing. NH: Conceptualization, Project administration, Supervision, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research and/or publication of this article.
Acknowledgments
A segment of this manuscript was presented during a session at The Japanese Society of Psychiatry and Neurology in Nagoya. In 2022, a paper titled “EVALUATION OF SEVERE AND CHRONIC FACTORS WHICH HAVE BEEN PROPOSED AS PRE-ESTABLISHED CRITERIA FOR PROLONGED HOSPITALIZATION IN THE MEDICAL TREATMENT AND SUPERVISION ACT WARD IN JAPAN” was authored and published in the Yamanashi Medical Journal (38).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1653427/full#supplementary-material
References
1. Nakatani Y, Kojimoto M, Matsubara S, and Takayanagi I. New legislation for offenders with mental disorders in Japan. Int J Law Psychiatry. (2010) 33:7–12. doi: 10.1016/j.ijlp.2009.10.005
2. Shiina A, Iyo M, and Igarashi Y. Defining outcome measures of hospitalization for assessment in the Japanese forensic mental health scheme: a Delphi study. Int J Ment Health Syst. (2015) 9:7. doi: 10.1186/1752-4458-9-7
3. Koike J, Harima H, Miyagi J, Morita N, and Nakatani Y. Cases of long-term hospitalization among patients with mental disorders having a criminal record: a focus on factors hindering social reintegration. Clin Psychiatry. (2014) 56:931–40. doi: 10.11477/mf.1405200025
4. Ando K, Soshi T, Nakazawa K, Noda T, and Okada T. Risk factors for problematic behaviors among forensic outpatients under the medical treatment and supervision act in Japan. Front Psychiatry. (2016) 7:144. doi: 10.3389/fpsyt.2016.00144
5. Takeda K, Sugawara N, Matsuda T, Shimada A, Nagata T, Kashiwagi H, et al. Mortality and suicide rates in patients discharged from forensic psychiatric wards in Japan. Compr Psychiatry. (2019) 95:152131. doi: 10.1016/j.comppsych.2019.152131
6. Fujii C, Fukuda Y, Ando K, Kikuchi A, and Okada T. Development of forensic mental health services in Japan: working towards the reintegration of offenders with mental disorders. Int J Ment Health Syst. (2014) 8:21. doi: 10.1186/1752-4458-8-21
7. Ministry of Health, Labor and Welfare. Enforcement of the law on Medical Care and Observation of Persons Who Have Committed Serious Harm While in a State of Mental Incapacity (2005). Available online at: https://www.mhlw.go.jp/web/t_doc?dataId=00tb3160&dataType=1&pageNo=1 (Accessed June 1, 2025).
8. Murata Y. The medical treatment and supervision act and occupational therapy: from a rehabilitation perspective. Sogo Rehabil. (2023) 51:989–94. doi: 10.11477/mf.1552202928
9. Naotsugu H. Research on the development of new therapeutic intervention methods and indicators related to behavior control under the Medical Observation Act: National Research and Development Agency, Japan Agency for Medical Research and Development, Longevity and Disability Comprehensive Research Project, Comprehensive Research and Development Project for Persons with Disabilities (Mental Disorders Field) (2017). FY2016 General and Shared Research and Development Report. Available online at: https://ndlsearch.ndl.go.jp/en/books/R100000002-I028168482 (Accessed June 1, 2025).
10. Kirchebner J, Günther MP, Sonnweber M, King A, and Lau S. Factors and predictors of length of stay in offenders diagnosed with schizophrenia - a machine-learning-based approach. BMC Psychiatry. (2020) 20:201. doi: 10.1186/s12888-020-02612-1
11. Gosek P, Kotowska J, Rowińska-Garbień E, Bartczak D, and Heitzman J. Treatment resistance and prolonged length of stay among schizophrenia inpatients in forensic institutions. Psychiatry Res. (2021) 298:113771. doi: 10.1016/j.psychres.2021.113771
12. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, and Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow-up. J Pers Disord. (2005) 19:505–23. doi: 10.1521/pedi.2005.19.5.505
13. Völlm B, Edworthy R, Holley J, Talbot E, Majid S, Duggan C, et al. A mixed-methods study exploring the characteristics and needs of long-stay patients in high and medium secure settings in England: implications for service organisation. Health Serv Delivery Res. (2017) 5. doi: 10.3310/hsdr05110
14. Tachimori H, Takeshima T, Kono T, Akazawa M, and Zhao X. Statistical aspects of psychiatric inpatient care in Japan: based on a comprehensive nationwide survey of psychiatric hospitals conducted from 1996 to 2012. Psychiatry Clin Neurosci. (2015) 69:512–22. doi: 10.1111/pcn.12297
15. Doyle M, Coid J, Ullrich S, and Shaw J. Assessing protective factors to prevent post-discharge violent behaviour: towards an assets-based approach for clinical risk management. J Psychiatr Res. (2021) 143:416–21. doi: 10.1016/j.jpsychires.2021.10.010
16. Chen E, Bazargan-Hejazi S, Ani C, Hindman D, Pan D, Ebrahim G, et al. Schizophrenia hospitalization in the US 2005-2014: Examination of trends in demographics, length of stay, and cost. Med (Baltimore). (2021) 100:e25206. doi: 10.1097/md.0000000000025206
17. Furlanetto LM, da Silva RV, and Bueno JR. The impact of psychiatric comorbidity on length of stay of medical inpatients. Gen Hosp Psychiatry. (2003) 25:14–9. doi: 10.1016/s0163-8343(02)00236-0
18. Anzai N. Research into determining the severity of mental disorders and the treatment system for severe patients (2014). Available online at: https://mhlw-grants.niph.go.jp/project/22777 (Accessed June 1, 2025).
19. Ministry of Health, Labour and Welfare. Minutes of the 2nd meeting of the Subcommittee on the New Regional Mental Health Care System (2016). Available online at: https://www.mhlw.go.jp/stf/shingi2/0000124387.html (Accessed June 1, 2025).
20. Madhur B, Sapkota N, Limbu S, and Baral D. Length of stay of psychiatric admissions in a tertiary care hospital. JNMA J Nepal Med Assoc. (2018) 56:593–7. doi: 10.31729/jnma.3472
21. Cechnicki A, Cichocki L, Kalisz A, Bladzinski P, Adamczyk P, and Franczyk-Glita J. Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study. Psychiatry Res. (2014) 219:420–5. doi: 10.1016/j.psychres.2014.05.046
22. Wu C, Ye J, Li S, Wu J, Wang C, Yuan L, et al. Predictors of everyday functional impairment in older patients with schizophrenia: A cross-sectional study. Front Psychiatry. (2023) 13:1081620. doi: 10.3389/fpsyt.2022.1081620
23. Colasanti A, Paletta S, Moliterno D, Mazzocchi A, Marui MC, and Altamura AC. Symptom dimensions as predictors of clinical outcome, duration of hospitalization, and aggressive behaviours in acutely hospitalized patients with psychotic exacerbation. Clin Pract Epidemiol Ment Health. (2010) 6:72–8. doi: 10.2174/1745017901006010072
24. Mino Y, Oshima I, and Shimodera S. Association between feasibility of discharge, clinical state, and patient attitude among inpatients with schizophrenia in Japan. Psychiatry Clin Neurosci. (2009) 63:344–9. doi: 10.1111/j.1440-1819.2009.01950.x
25. Tanioka T, Chiba S, Onishi Y, Kataoka M, Kawamura A, Tomotake M, et al. Factors associated with discharge of long-term inpatients with schizophrenia in Japan: a retrospective study. Issues Ment Health Nurs. (2013) 34:256–64. doi: 10.3109/01612840.2012.742602
26. Broderick C, Azizian A, and Warburton K. Length of stay for inpatient incompetent to stand trial patients: importance of clinical and demographic variables. CNS Spectr. (2020) 25:734–42. doi: 10.1017/s1092852920001273
27. Tawandra L, Jianfang L, Gloria H, and Elaine L. Length of hospitalization and hospital readmissions among patients with substance use disorders in New York City, NY USA. Drug Alcohol Depend. (2020) 1:212.
28. David S, Laura F, and Robert G. Do suicidal ideation and behaviour influence duration of psychiatric hospitalization? Int J Ment Health Nurs. (2002) 4:220–4. doi: 10.1046/j.1440-0979.2002.00252.x
29. Richard KR, Christine YF, Katherine AC, Peter PRB, and Joan ER. Substance-induced suicidal admissions to an acute psychiatric service: characteristics and outcomes. J Subst Abuse Treat. (2008) 1:72–9. doi: 10.1016/j.jsat.2006.12.033
30. Schoepf D, Uppal H, Potluri R, and Heun R. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci. (2014) 264:3–28. doi: 10.1007/s00406-013-0436-x
31. Canuso CM and Goldman MB. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. J Neuropsychiatry Clin Neurosci. (1999) 11:86–90. doi: 10.1176/jnp.11.1.86
32. Erkiran M, Ozünalan H, Evren C, Aytaçlar S, Kirisci L, and Tarter R. Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder. Addict Behav. (2006) 31:1797–805. doi: 10.1016/j.addbeh.2005.12.024
33. Noohi S, Kalantari S, Hasanvandi S, and Elikaei M. Determinants of length of stay in a psychiatric ward: a retrospective chart review. Psychiatr Q. (2020) 91:273–87. doi: 10.1007/s11126-019-09699-0
34. Morris BG. Brain circuit dysfunction in a distinct subset of chronic psychotic patients. Schizophr Res. (2014) 157:204–13. doi: 10.1016/j.schres.2014.06.001
35. Oddur I, James HM, and Engilbert S. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland. Nord J Psychiatry. (2018) 72:497–500. doi: 10.1080/08039488.2018.1517189
36. Takahiro H, Kae I, Kentaro S, Mari I, Masahiro O, and Koichiro T. Risk factors for pneumonia in patients with schizophrenia. Neuropsychopharmacol Rep. (2018) 38:204–9. doi: 10.1002/npr2.12034
37. Correll CU, Ng-Mak DS, Stafkey-Mailey D, Farrelly E, Rajagopalan K, and Loebel A. Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis. Ann Gen Psychiatry. (2017) 16:9. doi: 10.1186/s12991-017-0133-7
38. Takeda N, Kashiwagi H, Watanabe N, and Hirabayashi N. Evaluation of severe and chronic factors which have been proposed as pre-established criteria for prolonged hospitalization in the medical treatment and supervision act ward in Japan. Yamanashi Med J. (2023) 37(1):31–41. doi: 10.34429/00005248
Keywords: forensic psychiatry, severe and chronic criteria, psychiatric symptoms, behavioral disorders, life disorders, length of hospitalization
Citation: Takeda N, Kashiwagi H, Watanabe N and Hirabayashi N (2025) Evaluation of severe and chronic factors for extended stays in Japanese medical treatment and supervision act wards. Front. Psychiatry 16:1653427. doi: 10.3389/fpsyt.2025.1653427
Received: 25 June 2025; Accepted: 20 October 2025;
Published: 27 November 2025.
Edited by:
Yasin Hasan Balcioglu, Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, TürkiyeReviewed by:
Gábor Gazdag, Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet, HungaryPınar Çelikkıran Erdem, Istanbul Bakırköy Mazhar Osman Training and Research Hospital for Psychiatry Neurology and Neurosurgery, Türkiye
Copyright © 2025 Takeda, Kashiwagi, Watanabe and Hirabayashi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Naoya Takeda, dGFrZWRhbkBuY25wLmdvLmpw
†Present address: Norio Watanabe, Department of Health Promotion and Human Behavior, School of Public Health, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan
Hiroko Kashiwagi1